Major Causes of Hospital Admission in Beta Thalassemia Major Patients in Southern Iran

被引:0
作者
Karimi, Mehran [1 ]
Emadmarvasti, Vahid [1 ]
Hoseini, Jacob [1 ]
Shoja, Lotfolah [1 ]
机构
[1] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
关键词
Beta Thalassemia major; Hospitalization; Complication; Iran; TRANSFUSION-DEPENDENT PATIENTS; COMPLICATIONS; SURVIVAL; DEFEROXAMINE; HEART;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Beta thalassemia major is a prevalent hereditary disease in Mediterranean region especially Iran. Early blood transfusion is necessary for most of the patients and frequent transfusion can cause various medical problems for the patients. The aim of this study was to find major causes of hospital admission in beta thalassemia major patients to reach the accurate preventive and therapeutic plans for these patients. Methods: Four hundred twenty six patients were admitted to the Nemazee Hospital (the main University referral Hospital Center affiliated to Shiraz University of Medical Sciences in Fars Province, southern Iran) during 3 years period (January 2007 to January 2010). A questionnaire was filled containing age, gender, hemoglobin level, frequency of blood transfusions, deferoxamine injection, cause of hospital admission and hospital course. Findings: The mean age of patients was 11.28 years. The mean serum ferritin level was 1820 749 mu g/lit. Two hundred fifty five (59.75%) patients were male and 171 (40.25%) patients were female. The top five most prevalent causes of hospital admission were splenectomy (21.8%), infections (19.9%), congestive heart failure (19.0%), diabetes mellitus (13.4%), and Liver biopsy (11.5%). (P=0.0002) Conclusion: Results of this study revealed that infections and complications due to iron overload are major causes of hospital admission in beta thalassemia major patients.
引用
收藏
页码:509 / 513
页数:5
相关论文
共 14 条
  • [1] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
    Angelopoulos, NG
    Goula, A
    Rombopoulos, G
    Kaltzidou, V
    Katounda, E
    Kaltsas, D
    Tolis, G
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (02) : 138 - 145
  • [2] BARZGAR M, 2011, PEDIATR HEMAT ONCOL, V28, P134
  • [3] Survival and complications in thalassemia
    Borgna-Pignatti, C
    Cappellini, MD
    De Stefano, P
    Del Vecchio, GC
    Forni, GL
    Gamberini, MR
    Ghilardi, R
    Origa, R
    Piga, A
    Romeo, MA
    Zhao, H
    Cnaan, A
    [J]. COOLEY'S ANEMIA EIGHTH SYMPOSIUM, 2005, 1054 : 40 - 47
  • [4] Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187
  • [5] EFFICACY OF DEFEROXAMINE IN PREVENTING COMPLICATIONS OF IRON OVERLOAD IN PATIENTS WITH THALASSEMIA MAJOR
    BRITTENHAM, GM
    GRIFFITH, PM
    NIENHUIS, AW
    MCLAREN, CE
    YOUNG, NS
    TUCKER, EE
    ALLEN, CJ
    FARRELL, DE
    HARRIS, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (09) : 567 - 573
  • [6] Complications of β-thalassemia major in north America
    Cunningham, MJ
    Macklin, EA
    Neufeld, EJ
    Cohen, AR
    [J]. BLOOD, 2004, 104 (01) : 34 - 39
  • [7] Haghshenas M, 1997, THALASSEMIA
  • [8] Malignancies in Patients With β-Thalassemia Major and β-Thalassemia Intermedia: A Multicenter Study in Iran
    Karimi, Mehran
    Giti, Rahil
    Haghpanah, Sezaneh
    Azarkeivan, Azita
    Hoofar, Hamid
    Eslami, Masoomeh
    [J]. PEDIATRIC BLOOD & CANCER, 2009, 53 (06) : 1064 - 1067
  • [9] Ultrastructural pathology of the heart in patients with β-thalassaemia major
    Kyriacou, K
    Michaelides, Y
    Senkus, R
    Simamonian, K
    Pavlides, N
    Antoniades, L
    Zambartas, C
    [J]. ULTRASTRUCTURAL PATHOLOGY, 2000, 24 (02) : 75 - 81
  • [10] Liver disease in transfusion dependent thalassaemia major
    Li, CK
    Chik, KW
    Lam, CWK
    To, KF
    Yu, SCH
    Lee, V
    Shing, MMK
    Cheung, AYK
    Yuen, PMP
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 86 (05) : 344 - 347